EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pentamidine inhibition of streptopain attenuates Streptococcus pyogenes virulence

Keya Trivedi, Christopher N LaRock iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.00758-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Keya Trivedi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Streptococcus pyogenes, Exotoxins, Pentamidine, Bacterial Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The obligate human pathogen Streptococcus pyogenes (also known as GAS; Group A Streptococcus ) carries high morbidity and mortality, primarily in impoverished or resource-poor regions. The failure rate of monotherapy with conventional antibiotics is high, and invasive infections by this bacterium frequently require extensive supportive care and surgical intervention. Thus, it is important to find new compounds with adjunctive therapeutic benefits. The conserved secreted protease streptopain (Streptococcal pyogenic exotoxin B; SpeB) directly contributes to disease pathogenesis by inducing pathological inflammation, degrading tissue, and promoting the evasion of antimicrobial host defense proteins. This study screened 400 diverse off-patent drugs and drug-like compounds for inhibitors of streptopain proteolysis. Lead compounds were tested for activity at lower concentrations and anti-virulence activities during in vitro infection. Significant inhibition of streptopain was seen for pentamidine, an anti-protozoal drug approved for the treatment of Pneumocystis pneumonia, leishmaniasis, and trypanosomiasis. Streptopain inhibition rendered GAS susceptible to killing by human innate immune cells. These studies identify unexploited molecules as new starting points for drug discovery and a potential for repurposing existing drugs for the treatment of infections by GAS. IMPORTANCE Streptococcus pyogenes is a common cause of severe invasive infections. Repeated infections can trigger autoimmune diseases such as acute rheumatic fever and rheumatic heart disease. This study examines how targeting a specific, highly conserved virulence factor of the secreted cysteine protease streptopain can sensitize a serious pathogen to killing by the immune system. Manipulating the host-pathogen interaction, rather than attempting to directly kill a microbe, is a promising therapeutic strategy. Notably, its benefits include limiting off-target effects on the microbiota. Streptopain inhibitors, including the antifungal and antiparasitic drug pentamidine as identified in this work, may therefore be useful in the treatment of S. pyogenes infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus pyogenesExotoxinsPentamidineBacterial ProteinsAnti-Bacterial AgentsHumansVirulenceStreptococcal InfectionsVirulence FactorsCysteine Endopeptidases

Stichwörter der Autor:innen

Streptococcus pyogenesanti-infectiveantibioticsdrug repurposingproteasevirulence factor

Substanzen

ExotoxinsPentamidinestreptopainBacterial ProteinsAnti-Bacterial AgentsVirulence FactorsCysteine Endopeptidases

Autor:innen und Institutionen

  • Department of Biology, Emory University, Atlanta, Georgia, USA.
  • Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Medicine, Division of Infectious Disease, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Antimicrobial Resistance Center, Emory University, Atlanta, Georgia, USA.

ORCID-Profile: Christopher N LaRock

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • NIH HHS
  • Burroughs Wellcome Fund
  • National Institutes of Health

Zitieren

APA

Trivedi, K., & LaRock, C. N. (2025). Pentamidine inhibition of streptopain attenuates Streptococcus pyogenes virulence. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00758-25

Vancouver

Trivedi K, LaRock CN. Pentamidine inhibition of streptopain attenuates Streptococcus pyogenes virulence. Microbiology Spectrum. 2025. doi:10.1128/spectrum.00758-25

BibTeX
@article{Trivedi2025,
  author = {Trivedi, Keya and LaRock, Christopher N},
  title = {Pentamidine inhibition of streptopain attenuates Streptococcus pyogenes virulence},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.00758-25}
}
Kostenlos starten →